vs

Side-by-side financial comparison of Equillium, Inc. (EQ) and VerifyMe, Inc. (VRME). Click either name above to swap in a different company.

VerifyMe, Inc. is the larger business by last-quarter revenue ($5.0M vs $4.4M, roughly 1.1× Equillium, Inc.). VerifyMe, Inc. runs the higher net margin — -66.7% vs -131.9%, a 65.2% gap on every dollar of revenue. On growth, VerifyMe, Inc. posted the faster year-over-year revenue change (-7.4% vs -52.3%). Over the past eight quarters, VerifyMe, Inc.'s revenue compounded faster (-5.2% CAGR vs -29.7%).

Equillium, Inc. is a clinical-stage biotechnology company focused on developing novel therapies for severe autoimmune and inflammatory diseases with high unmet medical needs. It advances pipeline candidates targeting immune system dysregulation, primarily catering to patients and healthcare providers across the United States.

VerifyMe, Inc. is a technology provider specializing in identity verification, anti-counterfeiting, and brand protection solutions. Its offerings include secure authentication tools, supply chain traceability systems, and customer engagement platforms, serving consumer goods, pharmaceutical, and retail sectors across North America and select global markets.

EQ vs VRME — Head-to-Head

Bigger by revenue
VRME
VRME
1.1× larger
VRME
$5.0M
$4.4M
EQ
Growing faster (revenue YoY)
VRME
VRME
+44.9% gap
VRME
-7.4%
-52.3%
EQ
Higher net margin
VRME
VRME
65.2% more per $
VRME
-66.7%
-131.9%
EQ
Faster 2-yr revenue CAGR
VRME
VRME
Annualised
VRME
-5.2%
-29.7%
EQ

Income Statement — Q4 FY2024 vs Q3 FY2025

Metric
EQ
EQ
VRME
VRME
Revenue
$4.4M
$5.0M
Net Profit
$-5.8M
$-3.4M
Gross Margin
41.2%
Operating Margin
-107.0%
-68.2%
Net Margin
-131.9%
-66.7%
Revenue YoY
-52.3%
-7.4%
Net Profit YoY
-147.4%
-38.4%
EPS (diluted)
$-0.16
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EQ
EQ
VRME
VRME
Q3 25
$5.0M
Q2 25
$4.5M
Q1 25
$4.5M
Q4 24
$4.4M
Q3 24
$12.2M
$5.4M
Q2 24
$13.9M
$5.4M
Q1 24
$10.7M
$5.8M
Q4 23
$9.2M
$8.7M
Net Profit
EQ
EQ
VRME
VRME
Q3 25
$-3.4M
Q2 25
$-291.0K
Q1 25
$-571.0K
Q4 24
$-5.8M
Q3 24
$-7.0K
$-2.4M
Q2 24
$468.0K
$-346.0K
Q1 24
$-2.7M
$-553.0K
Q4 23
$-2.3M
$2.0K
Gross Margin
EQ
EQ
VRME
VRME
Q3 25
41.2%
Q2 25
35.2%
Q1 25
33.4%
Q4 24
Q3 24
34.9%
Q2 24
39.1%
Q1 24
39.2%
Q4 23
33.0%
Operating Margin
EQ
EQ
VRME
VRME
Q3 25
-68.2%
Q2 25
-7.1%
Q1 25
-13.3%
Q4 24
-107.0%
Q3 24
-5.6%
-52.8%
Q2 24
-0.7%
-10.0%
Q1 24
-26.1%
-11.2%
Q4 23
-34.7%
0.8%
Net Margin
EQ
EQ
VRME
VRME
Q3 25
-66.7%
Q2 25
-6.4%
Q1 25
-12.8%
Q4 24
-131.9%
Q3 24
-0.1%
-44.6%
Q2 24
3.4%
-6.5%
Q1 24
-25.6%
-9.6%
Q4 23
-25.4%
0.0%
EPS (diluted)
EQ
EQ
VRME
VRME
Q3 25
$-0.26
Q2 25
$-0.02
Q1 25
$-0.05
Q4 24
$-0.16
Q3 24
$0.00
$-0.23
Q2 24
$0.01
$-0.03
Q1 24
$-0.08
$-0.05
Q4 23
$-0.06
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EQ
EQ
VRME
VRME
Cash + ST InvestmentsLiquidity on hand
$18.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$19.1M
$11.1M
Total Assets
$25.6M
$13.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EQ
EQ
VRME
VRME
Q3 25
Q2 25
Q1 25
Q4 24
$18.1M
Q3 24
$15.4M
$2.6M
Q2 24
$11.1M
$2.9M
Q1 24
$11.6M
$2.8M
Q4 23
$23.2M
$3.0M
Total Debt
EQ
EQ
VRME
VRME
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$500.0K
Q2 24
$600.0K
Q1 24
$800.0K
Q4 23
$875.0K
Stockholders' Equity
EQ
EQ
VRME
VRME
Q3 25
$11.1M
Q2 25
$14.4M
Q1 25
$14.6M
Q4 24
$19.1M
Q3 24
$23.2M
$10.3M
Q2 24
$22.4M
$12.3M
Q1 24
$21.1M
$12.4M
Q4 23
$22.6M
Total Assets
EQ
EQ
VRME
VRME
Q3 25
$13.3M
Q2 25
$17.2M
Q1 25
$17.1M
Q4 24
$25.6M
Q3 24
$34.5M
$14.8M
Q2 24
$42.9M
$17.5M
Q1 24
$43.6M
$17.9M
Q4 23
$50.5M
$20.7M
Debt / Equity
EQ
EQ
VRME
VRME
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.05×
Q2 24
0.05×
Q1 24
0.06×
Q4 23

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EQ
EQ
VRME
VRME
Operating Cash FlowLast quarter
$-3.3M
$243.0K
Free Cash FlowOCF − Capex
$-3.3M
FCF MarginFCF / Revenue
-75.2%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EQ
EQ
VRME
VRME
Q3 25
$243.0K
Q2 25
$710.0K
Q1 25
$-404.0K
Q4 24
$-3.3M
Q3 24
$-7.7M
$-10.0K
Q2 24
$730.0K
$372.0K
Q1 24
$-8.8M
$-60.0K
Q4 23
$-5.7M
$843.0K
Free Cash Flow
EQ
EQ
VRME
VRME
Q3 25
Q2 25
Q1 25
Q4 24
$-3.3M
Q3 24
$-12.0K
Q2 24
$668.0K
$369.0K
Q1 24
$-8.8M
$-62.0K
Q4 23
$840.0K
FCF Margin
EQ
EQ
VRME
VRME
Q3 25
Q2 25
Q1 25
Q4 24
-75.2%
Q3 24
-0.2%
Q2 24
4.8%
6.9%
Q1 24
-82.5%
-1.1%
Q4 23
9.6%
Capex Intensity
EQ
EQ
VRME
VRME
Q3 25
Q2 25
Q1 25
Q4 24
0.1%
Q3 24
0.0%
0.0%
Q2 24
0.4%
0.1%
Q1 24
0.2%
0.0%
Q4 23
0.0%
Cash Conversion
EQ
EQ
VRME
VRME
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
1.56×
Q1 24
Q4 23
421.50×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EQ
EQ

Segment breakdown not available.

VRME
VRME

Proactive Services$4.2M83%
Other$869.0K17%

Related Comparisons